ZNF85 and serum lipopolysaccharide activity: A deglycosylated version of KKO, which works in concert with hPF4 to reduce NDP release and enhance NET capture of bacteria, markedly improved survival in murine LPS endotoxemia and polymicrobial sepsis (13, 32, 37).